VCP
OGN icon

Verus Capital Partners’s Organon & Co OGN Stock Holding History

Verus Capital Partners’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-31,519
Closed -$469K – 398
2025
Q1 		$469K Buy
31,519
+859
+3% +$13.2K 0.05% 213
2024
Q4 		$435K Buy
30,660
+11,000
+56% +$179K 0.04% 218
2024
Q3 		$376K Buy
19,660
+7,751
+65% +$161K 0.04% 232
2024
Q2 		$247K Sell
11,909
-115
-1% -$2.29K 0.03% 292
2024
Q1 		$226K Buy
12,024
+1,201
+11% +$20.6K 0.03% 317
2023
Q4 		$156K Buy
+10,823
New +$147K 0.02% 313

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Verus Capital Partners's OGN Position: Q2 2025 in Review

Verus Capital Partners sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 31,519 shares — an estimated $469K sold.

Verus Capital Partners first reported a position in OGN in Q4 2023 and held it in 6 quarters. The position peaked at $469K in Q1 2025. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Verus Capital Partners reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Verus Capital Partners sold 31,519 Organon & Co shares in Q2 2025, an estimated $469K.
  • Verus Capital Partners first reported a position in Organon & Co in Q4 2023 and held it in 6 quarters.
  • Verus Capital Partners's Organon & Co position peaked at $469K in Q1 2025.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Verus Capital Partners's 13F filing for Q2 2025, filed 7 Aug 2025.